TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT IN MEDULLOBLASTOMA

被引：0
|
作者：
Richardson, Angela M. [1 ,2 ]
Collins, Sara A. [3 ]
Inagaki, Akihito [3 ]
Armstrong, L. [4 ]
Roussel, Martine [5 ]
Jolly, Douglas [6 ]
Robbins, David J. [7 ,8 ]
Ayad, Nagi [9 ]
Kasahara, Noriyuki [10 ,11 ]
机构：
[1] Univ Miami, Dept Neurol Surg, Miami, FL USA
[2] Jackson Hlth Syst, Neurosurg Program, Miami, FL USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[4] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[5] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA
[6] Tocagen Inc, San Diego, CA USA
[7] Univ Miami, Dept Surg, Miami, FL USA
[8] Univ Miami, Dept Biochem, Miami, FL USA
[9] Univ Miami, Miami, FL USA
[10] Univ Miami, Dept Cell Biol, Miami, FL USA
[11] Univ Miami, Dept Pathol, Miami, FL USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PDTM-19
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [31] COMBINATION TOCA 511 & 5-FC SIGNIFICANTLY EXTENDS SURVIVAL IN A MURINE ORTHOTOPIC MODEL OF IN rRACEREBELLAR MEDULLOBLAS TOMA
    Richardson, Angela
    Collins, Sara
    Inagaki, Akhito
    Armstrong, Valerie
    Roussel, Martine
    Robbins, David
    Ayad, Nagy
    Jolly, Douglas
    Kasahara, Noriyuki
    NEURO-ONCOLOGY, 2019, 21 : 120 - 120
  • [32] THE TOCA 7 STUDY: PHASE 1B STUDY OF TOCA 511, A LIVE GAMMA RETROVIRUS, AND TOCA FC, AN EXTENDED-RELEASE FORMULATION OF 5-FLUOROCYTOSINE COMBINED WITH STANDARD OF CARE IN NEWLY DIAGNOSED HIGH GRADE GLIOMA (NCT02598011)
    Vogelbaum, Michael
    Lassman, Andrew
    Lee, Ian
    Liau, Linda
    Sonabend, Adam
    Walbert, Tobias
    Yang, Liqiang
    Das, Asha
    Cloughesy, Timothy
    NEURO-ONCOLOGY, 2016, 18 : 2 - 2
  • [33] NRG ONCOLOGY NRG-BN006: A PHASE II/III RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511 AND TOCA FC WITH STANDARD OF CARE COMPARED TO STANDARD OF CARE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Pugh, Stephanie
    Ellingson, Benjamin
    Kotecha, Rupesh
    Cloughesy, Timothy
    Vogelbaum, Michael
    Aldapec, Kenneth
    Cu, Yunfeng
    Armstrong, Terri
    Mehta, Minesh
    NEURO-ONCOLOGY, 2019, 21 : 220 - 221
  • [34] Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
    Perez, Omar D.
    Logg, Christopher R.
    Hiraoka, Kei
    Diago, Oscar
    Burnett, Ryan
    Inagaki, Akihito
    Jolson, Dawn
    Amundson, Karin
    Buckley, Taylor
    Lohse, Dan
    Lin, Amy
    Burrascano, Cindy
    Ibanez, Carlos
    Kasahara, Noriyuki
    Gruber, Harry E.
    Jolly, Douglas J.
    MOLECULAR THERAPY, 2012, 20 (09) : 1689 - 1698
  • [35] Immune profile of tumor microenvironment helps predict response in patients treated with an investigational immunotherapeutic consisting of a retroviral replicating vector (Toca 511) and an extended-release formulation of 5-fluorocytosine (Toca FC)
    Ostertag, Derek
    Accomando, William
    Mitchell, Leah
    Rodriguez-Aguirre, Maria
    Hogan, Daniel
    Diago, Oscar
    Gammon, Dawn
    Haghighi, Ali
    Gruber, Harry
    Das, Asha
    Jolly, Douglas
    CANCER RESEARCH, 2018, 78 (13)
  • [36] Clinical and pre-clinical utility of genomics in medulloblastoma
    Nor, Carolina
    Ramaswamy, Vijay
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (08) : 633 - 647
  • [37] Toca 511 and 5-FC in Combination with Metronomic Cyclophosphamide Reduces Treg Cells and Enhances Therapy Efficacy in a Preclinical Murine Model
    Montellano, Tiffany T.
    Viaud, Sophie
    Mendoza, Daniel
    Rodriguez-Aguirre, Maria
    Gruber, Harry
    Jolly, Douglas
    Ostertag, Derek
    JOURNAL OF NEUROSURGERY, 2019, 131 (01)
  • [38] Mechanism of Action of a Retroviral Replicating Vector, TOCA 511 & 5-FC: Levels of Infection for Anti-Tumor Activity and Immunity
    Yagiz, Kader
    Hofacre, Andrew
    Lin, Amy
    Lopez-Espinoza, Fernando
    Mendoza, Daniel
    Munday, Anthony
    Mitchell, Leah
    Jolly, Douglas J.
    MOLECULAR THERAPY, 2017, 25 (05) : 58 - 59
  • [39] Therapeutic efficacy of anti-tumor immune responses activated by Toca 511/5-FC treatment in pancreatic cancer model
    Niwa, Hiroki
    Nakamura, Toru
    Kushiya, Hiroki
    Inoko, Kazuho
    Hiraoka, Kei
    Inagaki, Akihito
    Tsuchikawa, Takahiro
    Shichinohe, Toshiaki
    Jolly, Douglas
    Kasahara, Noriyuki
    Hirano, Satoshi
    CANCER SCIENCE, 2021, 112 : 808 - 808
  • [40] Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept
    Coppard, Celine
    Bonnefoy, Francis
    Hannani, Dalil
    Gabert, Francoise
    Manches, Olivier
    Plumas, Joel
    Perruche, Sylvain
    Chaperot, Laurence
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
12345